Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,159,520
-$2,417,904 QoQ
Shares Held
212,968
-44.5% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 424 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. ALKS ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,159,520 | 212,968 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,577,424 | 383,977 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $14,390,783 | 514,324 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $11,172,660 | 372,422 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $12,946,652 | 452,522 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $17,575,388 | 532,265 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $23,339,917 | 811,541 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $23,266,686 | 831,250 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $19,364,445 | 803,504 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $11,484,825 | 424,264 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $10,676,043 | 384,861 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $10,284,823 | 367,184 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,956,629 | 94,461 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,799,420 | 134,779 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,093,756 | 194,939 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,058,432 | 181,748 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,055,798 | 102,578 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,649,522 | 100,704 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,279,892 | 141,010 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,403,841 | 110,371 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,423,555 | 139,623 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,556,809 | 83,341 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,668,039 | 83,611 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $29,633,693 | 1,526,723 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $29,877,519 | 2,071,950 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||